Q2 FY2026 · ended Jun 30, 2026 · Revenue $1.38M, +10.8% YoY · Filed Aug 13, 2026
Target Group Inc. (CBDY) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $1.4 million and a net loss of $239,812. As of Jun 30, 2026 it held $5,914 in cash and investments and $8.2 million in total debt.
Revenue
$1.38M
+10.8% vs year-ago quarter
Net income
$-239,812
-9.1% vs year-ago quarter
Operating cash flow
$-222,908
-146.0% vs year-ago quarter
Free cash flow
—
EPS
$-0.00
+0.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
617.03M
+0.0% vs year-ago quarter
Net cash
$-8.24M
Q2 FY2026
Operating margin
—
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CBDY (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Hamilton
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1586554
- Former names
- Chess Supersite Corp (until Jul 3, 2018); River Run Acquisition Corp (until May 13, 2014)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.4M | $879,442 | $735,190 | $499,650 | $1.2M |
| Net income | -$239,812 | -$550,356 | -$552,307 | -$479,392 | -$219,770 |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 |
| Operating cash flow | -$222,908 | -$93,665 | -$250,788 | -$506,066 | $484,434 |
| Total assets | $5.7M | $6.1M | $6.2M | $6.2M | $6.6M |
| Total liabilities | $14.3M | $14.6M | $14.2M | $13.6M | $13.6M |
| Stockholders' equity | -$8.7M | -$8.5M | -$8.1M | -$7.4M | -$7.0M |
| Cash and investments | $5,914 | $201,647 | $100,410 | $337,488 | $837,497 |
| Total debt | $8.2M | $8.5M | $8.6M | $8.5M | $8.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| 8-K |
Current report
New debt
|
Aug 18, 2025 | Aug 11, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
All 254 Target Group Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.